Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2012

Jun 8, 2012

31971_dirs_2012-06-08_fdea8501-2fe7-4f0b-8509-070175461f67.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-06-06

Reporting Person: JONAS DANIEL (VP Legal Affairs, Gen. Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-06-06 Common Stock M 2000 $16.46 Acquired 11406 Direct
2012-06-06 Common Stock F 1508 $26.85 Disposed 9898 Direct
2012-06-06 Common Stock M 2000 $19.26 Acquired 11898 Direct
2012-06-06 Common Stock F 1640 $26.85 Disposed 10258 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-06-06 Sars (Stock Appreciation Rights) $16.46 M 2000 Disposed 2019-06-01 Common Stock (2000) Direct
2012-06-06 Sars (Stock Appreciation Rights) $19.26 M 2000 Disposed 2020-06-01 Common Stock (2000) Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.